Evidence for gut factor in K+ homeostasis.

Am J Physiol Renal Physiol

Dept. of Physiology and Biophysics, Keck School of Medicine, University of Southern California, 1333 San Pablo St., MMR 626, Los Angeles, CA 90089-9142, USA.

Published: August 2007

We tested the hypothesis that K(+) intake is sensed by putative K(+) sensors in the splanchnic areas, and renal K(+) handling is regulated by this signal. K(+) was infused for 2 h into overnight-fasted rats via the jugular vein (systemic infusion), hepatic portal vein (intraportal infusion), or stomach (intragastric infusion) (n = 5 each), and plasma K(+) concentration ([K(+)]) and renal K(+) excretion were measured during the 2-h preinfusion, 2-h K(+) infusion, and 3-h washout periods. During systemic K(+) infusion, plasma [K(+)] increased by approximately 1.3 mM (P < 0.05), and, on cessation of the K(+) infusion, plasma [K(+)] fell to the preinfusion level within 1-2 h. Renal K(+) excretion changed in proportion to the changes in plasma [K(+)]. During intraportal or intragastric K(+) infusion, plasma [K(+)] and renal K(+) excretion profiles were similar to those with systemic infusion. The effects of K(+) infusions via the different routes (n = 5 or 6 each) were also studied during simultaneous feeding of overnight-fasted rats with a K(+)-deficient diet. During the meal, intraportal infusion resulted in increases in plasma [K(+)] similar to those with the systemic K(+) infusion, while intragastric K(+) infusion did not significantly increase plasma [K(+)]. Thus, when the intragastric K(+) infusion was combined with a meal, there was marked enhancement of clearance of the K(+) infused, which was associated with an apparent increase in renal efficiency of K(+) excretion. These data suggest that there may be a gut factor that enhances renal efficiency of K(+) excretion during meal (or dietary K(+)) intake.

Download full-text PDF

Source
http://dx.doi.org/10.1152/ajprenal.00427.2006DOI Listing

Publication Analysis

Top Keywords

plasma [k+]
24
systemic infusion
16
intragastric infusion
16
infusion plasma
16
infusion
12
renal excretion
12
gut factor
8
overnight-fasted rats
8
intraportal infusion
8
[k+] renal
8

Similar Publications

Aims: Gastrointestinal stromal tumors (GISTs) account for about 80% of the mesenchymal tumors of the GI tract. About 5000-6000 patients are diagnosed in the United States (US) alone, and up to 14.5 cases per million discovered in Europe annually.

View Article and Find Full Text PDF

Background: Piperine, a secondary metabolite, affects the antihyperlipidemic effect of Ezetimibe (EZ). Hyperlipidemia is one of the independent risk factors for cardiovascular disorders such as atherosclerosis. Antihyperlipidemic drugs are essential for reducing cardiovascular events and patient mortality.

View Article and Find Full Text PDF

Background: Perinatal growth and nutrition have been shown to be determinants in the programming of different tissues, such as adipose tissue, predisposing individuals to metabolic alterations later in life. Previous studies have documented an increased risk of metabolic disturbances and low-grade inflammation in prepubertal children with a history of extrauterine growth restriction (EUGR). The aim of this study was to evaluate possible alterations resulting from impaired growth during early childhood and their impact on young adult health.

View Article and Find Full Text PDF

Amyotrophic lateral sclerosis (ALS) lacks a specific biomarker, but is defined by relatively selective toxicity to motor neurons (MN). As others have highlighted, this offers an opportunity to develop a sensitive and specific biomarker based on detection of DNA released from dying MN within accessible biofluids. Here we have performed whole genome bisulfite sequencing (WGBS) of iPSC-derived MN from neurologically normal individuals.

View Article and Find Full Text PDF

Oral Administration of [F]MC225 for Quantification of P-glycoprotein Function: A Feasibility Study.

Mol Imaging Biol

January 2025

Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Purpose: This preclinical study explored the feasibility of assessing P-glycoprotein (P-gp) function in both brain and gastrointestinal (GI) tract of rats using positron emission tomography (PET) following oral administration of [F]MC225. Different oral administration protocols were evaluated, and radioactivity uptake was compared with uptake following intravenous administration.

Procedures: Twelve male Wistar rats were divided into four groups and subjected to intravenous or oral [F]MC225 administration protocols: G (intravenous route), G (oral administration without fasting), G (oral administration with fasting), and G (oral administration with fasting following administration of the P-gp inhibitor tariquidar).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!